Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 6, 2014, Pages

  Wang, Shaoxiong ^a,b   Lu, Xi ^a,b   Yang, Jian ^a,b   Wang, Hongyong ^a,b   Chen, Cai Yu ^a,b   Han, Yu ^a,b   Ren, Hongmei ^a,b   Zheng, Shuo ^a,b   He, Duofen ^a,b   Zhou, Lin ^a,b   Asico, Laureano D ^c   Wang, Wei Eric ^a,b   Jose, Pedro A ^c   Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Museum   (China)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine receptor; Hypertension; Renal proximal tubule cells; Renalase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTISENSE OLIGONUCLEOTIDE; BETA ACTIN; CYCLOHEXIMIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; FENOLDOPAM; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RENALASE; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PHYSIOLOGY; RENAL PROXIMAL TUBULE CELLS; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

DOPAMINE RECEPTOR; HYPERTENSION; RENAL PROXIMAL TUBULE CELLS; RENALASE;

ANIMALS; CELLS, CULTURED; FENOLDOPAM; KIDNEY TUBULES, PROXIMAL; MALE; MONOAMINE OXIDASE; PROTEIN KINASE C; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5;

EID: 84900333630     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00196.2013     Document Type: Article

References (49)

1. Baines AD, Craan A, Chan W, Morgunov N. Tubular secretion and metabolism of dopamine, norepinephrine, methoxytyramine and normetanephrine by the rat kidney. J Pharmacol Exp Ther 208: 144-147, 1979
2. Baines AD, Drangova R. Dopamine production by the isolated perfused rat kidney. Can J Physiol Pharmacol 62: 272-276, 1984
3. +-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol Renal Fluid Electrolyte Physiol 254: F795-F801, 1988
4. Bobalova J, Mutafova-Yambolieva VN. Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery. Eur J Pharmacol 536: 128-132, 2006
5. Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med 13: 321-327, 2011
6. Burgi K, Cavalleri MT, Alves AS, Britto LR, Antunes VR, Michelini LC. Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats. Am J Physiol Regul Integr Comp Physiol 300: R264-R271, 2011
7. Carranza A, Karabatas L, Barontini M, Armando I. Decreased tubular uptake of L-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats. Horm Res 55: 282-7, 2001
8. Cho S, Duchemin AM, Neff NH, Hadjiconstantinou M. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs. Brain Res 830: 237-45, 1999
9. Chu HY, Yang Z, Zhao B, Jin GZ, Hu GY, Zhen X. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro. Brain Res 1343: 20-27, 2010
10. Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne-Reineke C, Unger T, Kintscher U. PPAR γ-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 46: 137-143, 2005
11. Cuk M, Cuk D, Dvornik S, Mamula O, Manestar MM. Recent findings regarding physiological characteristics and effects of renal dopamine. Lijec Vjesn 126: 147-155, 2004
12. Dahmer MK, Senogles SE. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. J Neurochem 66: 222-232, 1996
13. Damase-Michel C, Montastruc JL, Tran MA. Effects of dopaminergic drugs on the sympathoadrenal system. Hypertens Res 18, Suppl 1: S119-S124, 1995
14. Desir G. Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol 27: 719-725, 2012
15. Desir GV. Role of renalase in the regulation of blood pressure and the renal dopamine system. Curr Opin Nephrol Hypertens 20: 31-36, 2011
16. Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One 5: e13496, 2010
17. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99: 3872-3877, 2002
18. Ferrari M, Cosentino M, Marino F, Bombelli R, Rasini E, Lecchini S, Frigo G. Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes. Biochem Pharmacol 67: 865-873, 2004
19. Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 51: 360-366, 2008
20. Hale TM, Robertson SJ, Burns KD, deBlois D. Short-term ACE inhibition confers long-term protection against target organ damage. Hypertens Res 35: 604-610, 2012
21. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002
22. Huang H, Ren H, Chen C, Wang X, Yang J, Han Y, He D, Zhou L, Asico LD, Jose PA, Zeng C. D3 dopamine receptor regulation of D5 receptor expression and function in renal proximal tubule cells. Hypertens Res 35: 639-647, 2012
23. 2+ channels in marginal cells in the stria vascularis of guinea pigs. J Physiol Sci 57: 287-298, 2007
24. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182, 1998
25. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. T3 increases Na-K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L749-L754, 2008
26. Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, Desir GV. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation 117: 1277-1282, 2008
27. Zeng C, Wang D, Yang Z, Wang Z, Asico LD, Wilcox CS, Eisner GM, Welch WJ, Felder RA, Jose PA. D1 dopamine receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 43: 673-679, 2004
28. Motley ED, Eguchi K, Gardner C, Hicks AL, Reynolds CM, Frank GD, Mifune M, Ohba M, Eguchi S. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-α. Hypertension 41: 775-780, 2003
29. Rohlicek CV, Matsuoka T, Saiki C. Cardiovascular response to acute hypoxemia in adult rats hypoxemic neonatally. Cardiovasc Res 53: 263-270, 2002
30. Rump LC, Schwertfeger E, Schaible U, Schuster MJ, Frankenschmidt A, Schollmeyer P. Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices. Eur J Clin Pharmacol 44, Suppl 1: S47-S49, 1993
31. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA. Amelioration of genetic hypertension by suppression of renal G proteincoupled receptor kinase type 4 expression. Hypertension 47: 1131-9, 2006
32. Stephenson RK, Sole MJ, Baines AD. Neural and extraneural catecholamine production by rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 242: F261-F266, 1982
33. Tayebati SK, Lokhandwala MF, Amenta F. Dopamine and vascular dynamics control: present status and future perspectives. Curr Neurovasc Res 8: 246-257, 2011
34. Van den Buuse M, Tritton SB, Burke SL, Head GA. Interaction of the dopamine D2 receptor agonist quinpirole with sympathetic vasomotor tone and the central action of rilmenidine in conscious rabbits. J Auton Nerv Syst 72: 187-194, 1998
35. Vernejoul F, Damase-Michel C, Montastruc JL, Tran MA. In vivo effects of fenoldopam on autonomic nervous system after inhibition or activation of ganglionic transmission. Eur J Pharmacol 444: 197-202, 2002
36. Wang X, Villar VA, Armando I, Eisner GM, Felder RA, Jose PA. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol 23: 2131-2146, 2008
37. Wang ZQ, Felder RA, Carey RM. Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension 33: 504-510, 1999
38. Weinman EJ, Biswas R, Steplock D, Wang P, Lau YS, Desir GV, Shenolikar S. Increased renal dopamine and acute renal adaptation to a high-phosphate diet. Am J Physiol Renal Physiol 300: F1123-F1129, 2011
39. Wu Y, Xu J, Velazquez H, Wang P, Li G, Liu D, Sampaio-Maia B, Quelhas-Santos J, Russell K, Russell R, Flavell RA, Pestana M, Giordano F, Desir GV. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int 79: 853-860, 2011
40. Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115: 1275-1280, 2005
41. + exchanger interactions in the kidney in hypertension. Hypertension 36: 395-399, 2000
42. Yang J, Chen C, Ren H, Han Y, He D, Zhou L, Hopfer U, Jose PA, Zeng C. Angiotensin II AT2 receptor decreases AT1 receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J Hypertens 30: 1176-1184, 2012
43. Yang Z, Sibley DR, Jose PA. D5 dopamine receptor knockout mice and hypertension. J Recept Signal Transduct Res 24: 149-164, 2004
44. Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D1-like receptors. Circulation 101: 2302-2308, 2000
45. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 294: H551-H569, 2008
46. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, Zheng S, Jones JE, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 99: 494-500, 2006
47. Zeng C, Villar VA, Yu P, Zhou L, Jose PA. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens 31: 156-178, 2009
48. Zhao Q, Fan Z, He J, Chen S, Li H, Zhang P, Wang L, Hu D, Huang J, Qiang B, Gu D. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med (Berl) 85: 877-885, 2007
49. Zheng S, Yu P, Zeng C, Wang Z, Yang Z, Andrews PM, Felder RA, Jose PA. Gα12-and Gα13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 41: 604-610, 2003.